Paul Hastings LLP advised Piper Sandler and Co. as lead placement agent, and Oppenheimer & Co. as placement agent in the transaction. Skye Bioscience, Inc. (OTCQB:...
Skye Bioscence’s $40 Million Private Placement Equity Financing
Skye Bioscience’s $50.25 Million Private Placement
Paul Hastings LLP advised the lead placement agent and the placement agent. Skye Bioscience, Inc. (OTCQB: SKYE), a clinical stage biotechnology company focused on the discovery,...
Voyager Therapeutics’ $100 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
actEvolent Health’s $402.5 Million Convertible Notes Offering
King & Spalding advised Evolent Health, Inc. on the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. Evolent Health, Inc. (NYSE:...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
Instacart’s $660 Million Initial Public Offering
Cooley advised Instacart, and Latham & Watkins advised the underwriters. Maplebear Inc. d/b/a Instacart announced the pricing of its initial public offering of 22,000,000 shares of its...
Air Transport Services Group’s Convertible Senior Notes Offering
Latham & Watkins Advises on Air Transport Services Group’s Convertible Senior Notes Offering. Air Transport Services Group, Inc. (NASDAQ: ATSG) has announced the pricing of its...
Savara’s $80 Million Common Stock Offering
Holland & Knight advised Savara, and Cooley advised the underwriters. Savara announced on July 13, 2023, the pricing of an underwritten offering of 21,000,000 shares of...
Intapp’s $228 Million Public Offering of Common Stock
Proskauer Rose advised Intapp, Latham & Watkins advised the underwriters, Sidley Austin advised Great Hill Equity Partners IV, L.P. and its affiliates, and Morrison & Foerster...
Viking Therapeutics’s $287.5 Million IPO
Mintz advised the syndicate of underwriters on the deal. Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
Vor Biopharma’s $115.8 Million Common Stock Offering and Private Placement
Latham & Watkins LLP represented the underwriters and placements agents in the transaction. Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced...
Sarepta Therapeutics’ $1.15 Billion Notes Offering
Goodwin Procter advised the initial purchasers on the deal. Sarepta Therapeutics, Inc. announced its Rule 144A offering of 1.25% Convertible Senior Notes due 2027. The $1.15 billion...